Etanautine: Difference between revisions
No edit summary |
m Protected "Etanautine": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
(One intermediate revision by one other user not shown) | |||
Line 2: | Line 2: | ||
| verifiedrevid = 447825139 | | verifiedrevid = 447825139 | ||
| IUPAC_name = 2-[di(phenyl)methoxy]-N,N-dimethylethanamine; 2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetic acid | | IUPAC_name = 2-[di(phenyl)methoxy]-N,N-dimethylethanamine; 2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetic acid | ||
| image = Etanautine. | | image = Etanautine.png | ||
<!--Clinical data--> | <!--Clinical data--> | ||
Line 56: | Line 56: | ||
== References == | == References == | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Line 65: | Line 64: | ||
[[Category:Antiparkinsonian agents]] | [[Category:Antiparkinsonian agents]] | ||
[[Category:Ethers]] | [[Category:Ethers]] | ||
[[Category:Drug]] |
Latest revision as of 20:37, 18 August 2015
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
ChemSpider | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C26H31N5O5 |
Molar mass | 493.555 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Etanautine |
Articles |
---|
Most recent articles on Etanautine |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Etanautine at Clinical Trials.gov Clinical Trials on Etanautine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Etanautine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Etanautine Discussion groups on Etanautine Patient Handouts on Etanautine Directions to Hospitals Treating Etanautine Risk calculators and risk factors for Etanautine
|
Healthcare Provider Resources |
Causes & Risk Factors for Etanautine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Etanautine, also known as diphenhydramine monoacefyllinate, is an anticholinergic used as an antiparkinsonian agent. It is a 1:1 salt of diphenhydramine with acefylline, similar to the diphenhydramine/8-chlorotheophylline combination product dimenhydrinate.
As with dimenhydrinate, the stimulant effect of the acefylline counteracts the sedative effect from the diphenhydramine, resulting in an improved therapeutic profile.
The 1:2 salt diphenhydramine diacefylline (with two molecules of acefylline to each molecule of diphenhydramine) is also used in medicine, under the brand name Nautamine.
References
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs with no legal status
- Antiparkinsonian agents
- Ethers
- Drug